Top 50 Medical Device VC Funds & Investors in Ireland (June 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Enterprise Ireland
VC Fund
|
37 | Ireland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $439k–$12M |
|
Western Development Commission
VC Fund
|
18 | Ireland, United States | Seed, Series A | Health Care, Medical Device, Biotechnology | $642k–$11M |
|
Irrus Investments
VC Fund
|
13 | Ireland, Sweden, United States | Seed, Series A | Health Care, Medical Device, Biotechnology | $713k–$8.8M |
|
Atlantic Bridge University Fund
VC Fund
|
12 | Ireland, United States | Seed, Series A | Medical Device, Health Care, Big Data | $823k–$12M |
|
HBAN
VC Fund
|
12 | Ireland, United Kingdom, United States | Seed, Series A | Health Care, Software, Medical Device | $625k–$8.8M |
|
SOSV
VC Fund
|
10 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
HBAN Medtech Syndicate
VC Fund
|
10 | Ireland | Seed, Series B | Medical Device, Medical, Health Care | $1.3M–$2.1M |
|
Atlantic Bridge
VC Fund
|
9 | United States, Ireland, United Kingdom | Series A, Series B | Software, Artificial Intelligence, Analytics | $4.5M–$62M |
|
Furthr VC
VC Fund
|
9 | Ireland | Seed, Pre-Seed | Medical Device, Medical, Software | $878k–$3.9M |
|
Elkstone Capital Partners
VC Fund
|
8 | Ireland, United Kingdom, United States | Seed, Series A | Software, Health Care, Information Technology | $610k–$20M |
|
Enterprise Equity
VC Fund
|
7 | Ireland, United States, United Kingdom | Seed, Series B | Software, Information Technology, Health Care | $549k–$7.5M |
|
EIT Health
VC Fund
|
6 | United Kingdom, Spain, Ireland | Grant, Pre-Seed, Seed | Health Care, Medical Device, Medical | $22k–$1.6M |
|
Fountain Healthcare Partners
VC Fund
|
6 | Ireland, United States, France | Series A, Series B, Series C | Health Care, Biotechnology, Medical | $3.3M–$110M |
|
Act Venture Capital
VC Fund
|
5 | Ireland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Artificial Intelligence | $823k–$13M |
|
EQT Life Sciences
VC Fund
|
5 | United States, The Netherlands, Switzerland | Series A, Series B, Series C | Biotechnology, Health Care, Therapeutics | $6.9M–$140M |
|
Ascentifi
VC Fund
|
4 | Ireland | Seed, Series A | Health Care, Medical Device, Medical | |
|
Xenium Capital
VC Fund
|
4 | Ireland | Seed | Medical Device, Health Care, Biotechnology | $2.5M–$3.8M |
|
Boole
VC Fund
|
4 | Ireland | Seed | Health Care, Medical Device, Medical | $3.8M–$3.8M |
|
Delta Partners
VC Fund
|
4 | Ireland, United States, United Kingdom | Seed, Series A | Software, Information Technology, Health Care | $795k–$6.6M |
|
AIB Seed Capital Fund
VC Fund
|
4 | Ireland, United States, Jersey | Seed, Series A | Software, Health Care, Medical | $549k–$8.1M |
|
Seroba Life Sciences
VC Fund
|
3 | Ireland, United States, United Kingdom | Series A, Series B | Health Care, Biotechnology, Medical | $4.6M–$105M |
|
NDRC
VC Fund
|
3 | Ireland, United States, United Kingdom | Seed, Pre-Seed, Convertible Note | Software, Information Technology, E-Commerce | |
|
Broadview Ventures
VC Fund
|
3 | United States, Canada, Israel | Series A, Seed, Series B | Health Care, Biotechnology, Medical Device | $1M–$45M |
|
Faber
VC Fund
|
3 | Portugal, United States, United Kingdom | Seed, Pre-Seed, Series A | Artificial Intelligence, Software, SaaS | $34k–$25M |
|
Boole Investment Syndicate
VC Fund
|
3 | Ireland, United States | Seed | Medical Device, SaaS, EdTech | $642k–$1.6M |
|
Medtech Syndicate Nominee
VC Fund
|
3 | Ireland | Seed, Series A | Medical, Health Care, Medical Device | |
|
Lightstone Ventures
VC Fund
|
3 | United States, Ireland, Singapore | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $7M–$105M |
|
Business Venture Partners
VC Fund
|
3 | Ireland, Luxembourg, The Netherlands | Seed, Series A | Health Care, Information Technology, Medical | $658k–$12M |
|
imec.xpand
VC Fund
|
2 | Belgium, United States, Germany | Seed, Series A, Series B | Semiconductor, Manufacturing, Medical Device | $3.3M–$100M |
|
SciFounders
VC Fund
|
2 | United States, Ireland, United Kingdom | Seed, Pre-Seed, Series A | Health Care, Medical, Therapeutics | $3.2M–$5M |
|
Life Sciences Fund Amsterdam
VC Fund
|
2 | Ireland, The Netherlands | Series A, Private Equity | Medical Device, Medical, Communities | |
|
Mayo Clinic Ventures
VC Fund
|
2 | United States, Ireland, China | Series A, Seed, Series B | Health Care, Biotechnology, Therapeutics | $1.4M–$69M |
|
CAJU Venture Partners
VC Fund
|
2 | Ireland | Health Care, Medical Device | ||
|
European Investment Bank
VC Fund
|
2 | France, Germany, The Netherlands | Debt Financing, Post-IPO Debt | Biotechnology, Health Care, Energy | $7.7M–$658M |
|
Glanzmann Enterprises
VC Fund
|
2 | Ireland | Series A | Medical, Health Care, Medical Device | |
|
Artis Ventures
VC Fund
|
2 | United States, India, Germany | Series A, Series B, Seed | Health Care, Biotechnology, Software | $2M–$127M |
|
Kernel Capital
VC Fund
|
2 | Ireland, United Kingdom, France | Seed, Series A | Software, Information Technology, Health Care | $531k–$9M |
|
Partisan Management Group
VC Fund
|
2 | United States, Ireland | Series A, Series B | Medical, Health Care, Biotechnology | $6.1M–$50M |
|
Gilde Healthcare
VC Fund
|
2 | United States, The Netherlands, Germany | Series B, Series C, Series A | Biotechnology, Health Care, Medical | $8.8M–$120M |
|
COSIMO Ventures
VC Fund
|
1 | Japan, Ireland, United States | Seed, Series A | Enterprise Software, Blockchain, Sports | |
|
TMC Venture Fund
VC Fund
|
1 | United States | Series A | Health Care, Life Science, Medical Device | |
|
Sanara MedTech
VC Fund
|
1 | Ireland | Corporate Round | Medical, Biotechnology, Medical Device | |
|
The University of Vermont Health Network
VC Fund
|
1 | United States, Ireland | Seed, Series B | Medical, Biotechnology, Fashion | |
|
Nipro Corporation
VC Fund
|
1 | Ireland | Seed | Health Care, Medical Device | |
|
Zoosh Group
VC Fund
|
1 | Ireland, United Kingdom | Pre-Seed, Seed | Software, SaaS, Information Technology | |
|
Grimpeur Holdings
VC Fund
|
1 | Ireland | Seed | Health Care, Medical Device, Health Diagnostics | |
|
Kidron
VC Fund
|
1 | France | Series B | Health Care, Medical Device | |
|
Bayern Kapital
VC Fund
|
1 | Germany, United States, Finland | Seed, Series A | Software, Health Care, Information Technology | |
|
Silicon Valley Bank
VC Fund
|
1 | United States, United Kingdom, Canada | Debt Financing, Series B, Series A | Software, Health Care, Biotechnology | |
|
Triventures
VC Fund
|
1 | United States, Israel, Ireland | Series B, Seed | Health Care, Medical Device, Medical | |
| Access all 142 VC funds in Ireland Medical Device startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 485
- Round size: Seed $439k–$3.3M; Series A $2.2M–$12M
- Lead/follow: 19% lead, 81% follow
- Last fund: May invest from a new fund soon — raised $1.1M in 2021
Portfolio highlights
- Tirlan — Tirlan is an agricultural company that supplies agri-food and farm input materials to the framing sector.
- Lakeland Dairies — Lakeland Dairies, a major dairy processing co-operative, operates within a fifteen county catchment area across the northern half of the island of Ireland. The Group processes about one billion litres of quality milk annually into a range of value added dairy foodservice products and functional dairy food ingredients.
- Touchtech Payments — At Touchtech Payments, believe in making industry changing and innovative technology.
Supporting communities to grow, investing in businesses to scale and planning for the future of the western region.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Series A
- Geography: Ireland, United States
Investor stats
- Total investments: 43
- Round size: Seed $642k–$3.7M; Series A $2.2M–$11M
- Lead/follow: 16% lead, 84% follow
Portfolio highlights
- Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
- Peroptyx — Peroptyx is a platform that provides managed solutions for machine learning. At Peroptyx, they have assembled and pre-screened a qualified network of data evaluators across the globe. They strategically match ideal evaluators with each product to ensure authentic experiences through consistency and appropriate real-world contexts.
- Galway Biomedical — Galway Biomedical partners with global medical device companies to bring complex braided devices from early concept through to full-scale production.
Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.
Show more...Investment focus
- Industry: Health Care, Medical Device, Biotechnology
- Stage:Seed, Series A
- Geography: Ireland, Sweden, United States
Investor stats
- Total investments: 34
- Round size: Seed $713k–$3.8M; Series A $2.2M–$8.8M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- Bounce Insights — Bounce Insights is a digital consumer research platform. It provides a direct link between brands and any consumer they needed to speak to by maintaining a community of active, engaged respondents on their mobile app.
- Adama Innovations — Adama Innovations have a disruptive technology for advanced manufacturing. The company have developed a simple process for creating patterns, on a scale invisible to the human eye, on ultra-hard materials.The micro patterns can be applied to injection molds and forming dies used for the fabrication of medical devices, improving theircapability and reducing the cost of manufacture. Other applications include labelling and anti-counterfeiting technology.The company's first product is a nano-scale probe fabricated in diamond, for metrology applications in high-tech manufacturing.The company is a spin-out from CRANN, the flagship nanotechnology institute in Trinity College Dublin.
- SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
We invest in entrepreneurs with the ambition to create world-class companies of scale.
Show more...Investment focus
- Industry: Medical Device, Health Care, Big Data
- Stage:Seed, Series A
- Geography: Ireland, United States
Investor stats
- Total investments: 30
- Round size: Seed $823k–$3.8M; Series A $3.1M–$12M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- AYLIEN — Aylien is an artificial intelligence startup that focuses on creating technologies that help machines understand human languages better. The firm provides Text Analysis and News API's that allow users to make sense of human-generated content at scale. AYLIEN also provides a range of content analysis solutions to developers, data scientists,marketers and academics. Their core offerings include packages of information retrieval, machine learning, natural language processing and image recognition APIs.
- CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
- ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
HBAN is dedicated to raising the profile of business angel investment as an asset class on the island of Ireland and to promote the creation of business angel syndicates.
Show more...Investment focus
- Industry: Health Care, Software, Medical Device
- Stage:Seed, Series A
- Geography: Ireland, United Kingdom, United States
Investor stats
- Total investments: 64
- Round size: Seed $625k–$3.5M; Series A $1.2M–$8.8M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — raised $10M in 2018
Portfolio highlights
- Movetru — Movetru a wearable device that aims to reduce injury and enhance rehabilitation.
- SeeMeHired — SeeMeHired is a cloud-based platform to automate much of the recruitment process, including engaging, selecting, and hiring job candidates.
- Mountain Technologies — Mountain Technologies is an innovative Northern Ireland-based startup that transforms mountain resort operational management.
SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
HBAN Medtech Syndicate
Show more...Investment focus
- Industry: Medical Device, Medical, Health Care
- Stage:Seed, Series B
- Geography: Ireland
Investor stats
- Total investments: 12
- Round size: Seed $1.3M–$2.1M
- Lead/follow: 17% lead, 83% follow
Portfolio highlights
- FeelTect — FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous.
- Neurobell — NeuroBell develop novel EEG medical devices for early detection and monitoring of neonatal seizures.
- SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
Atlantic Bridge is a Growth Equity Firm with a Cross Border Value Add strategy. We invest in deep technology companies in Europe and the US. Our team is made up of successful entrepreneurs and senior technology industry executives and we invest in strong ambitious entrepreneurs and management teams that have the passion and drive to scale up andexploit major growth opportunities. We help our portfolio companies expand and grow internationally through our global platform with our team and offices in London, Dublin, Munich, Paris and Palo Alto.Atlantic Bridge brings together a unique team of technology entrepreneurs, experienced managers, finance professionals, and investment experts. The team contains a wealth of international business experience across Europe, the UK and the US. They have worked together in various capacities for the last 30 years, bringing a true partnership approach to their firm and their investments. Its investors include the founders, leading institutional investors, and private investors with a track record of investment in successful technology companies.Atlantic Bridge has developed a unique and differentiated strategy that focuses on specific technology themes and the implementation of the “Atlantic Bridge Model” for scaling companies internationally. The “Bridge Model” accelerates the scale-up of technology companies in Europe and the US. This approach is highly differentiated and has delivered strong performance results to date.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Analytics
- Stage:Series A, Series B
- Geography: United States, Ireland, United Kingdom
Investor stats
- Total investments: 135
- Round size: Series A $4.5M–$26M; Series B $10M–$62M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $88M in 2021
Portfolio highlights
- Striim — Modern, reliable data integration across your private and public cloud. All in real-time with change data capture and data streams.
- HyperGrid™ — HyperCloud enables businesses to embrace public clouds and drive their digital transformation via the broadest set of functionalities to discover and plan cloud migrations, optimize costs, secure resource and scale operations in the public cloud. HyperCloud has a unique app-centric, modular approach that enables businesses to scale their cloudmanagement capabilities within a common framework that provides centralized control and management of all private and public clouds and eliminates the need for ongoing training. HyperCloud analytics is powered by its massive database of more than 400 million data points across the major public clouds enabling instantaneous recommendations for optimizing new and existing applications using multi-dimensional analysis of factors such as cost, performance, and compliance. HyperCloud also analyzes past cloud usage to understand customer needs and speed service delivery by eliminating manual processes. As a result, enterprise IT and MSPs can deliver customized services across any private or public cloud, improving business performance while minimizing cloud management complexities.
- Snowplow — Snowplow gives teams complete flexibility and control over how behavioral data is collected, structured, processed, modeled and stored.
We are a relationship driven early stage VC investor. We invest in and form close partnerships with the founders we back.We make initial investments at Seed to Series A stage in highly ambitious, born global Irish software and medtech companies. We are hands-on and support teams across key strategic areas to accelerate growth.In addition toproviding institutional investment at an early stage, we reserve significant capital for following on in subsequent rounds. We go the journey with founders.
Show more...Investment focus
- Industry: Medical Device, Medical, Software
- Stage:Seed, Pre-Seed
- Geography: Ireland
Investor stats
- Total investments: 26
- Round size: Seed $878k–$3.9M; Pre-Seed $878k–$2.2M
- Lead/follow: 38% lead, 62% follow
- Last fund: May invest from a new fund soon — raised $35M in 2019
Portfolio highlights
- Trustap — Learn how we make buying & selling online safe & secure, every time. Create an account for free today!
- LaNua Medical — At LaNua Medical it is our mission to develop disruptive image-guided technologies providing safe and effective endovascular solutions.
- STRATxAI — STRATxAI is a WealthTech Company based in Dublin, Ireland. Specialising in AI-driven model portfolios, combining decades of expertise with proprietary AI to serve Advisors and Institutional Investors. STRATxAI Model Portfolios are built to navigate market complexity and deliver attractive risk-adjusted returns. Through close collaboration withclients, we create bespoke portfolios tailored to their unique needs, preferences and risk profiles. Alana, our proprietary engine leverages advanced machine learning algorithms to streamline the implementation and management of adaptive. multi factor strategies.
Elkstone is an investment firm, focusing on entrepreneurs, senior executives, institutional LPs, the venture community, and the Irish diaspora.The objective of the organization is to boost the economic value and overall well-being of the island of Ireland by expanding a network, facilitating deserving investments, and delivering excellentinvestment performance.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Ireland, United Kingdom, United States
Investor stats
- Total investments: 83
- Round size: Seed $610k–$5M; Series A $5.5M–$20M
- Lead/follow: 48% lead, 52% follow
- Last fund: Likely still investing — raised $110M in 2023
Portfolio highlights
- Jamango — Create and play for free in Jamango! Play with our block-based tools to make anything or explore a library of games and worlds instantly. No downloads.
- LaNua Medical — At LaNua Medical it is our mission to develop disruptive image-guided technologies providing safe and effective endovascular solutions.
- Retrograde — Retrograde is a Software Development company.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Enterprise Equity (or EEVC) is an excellent for providing capital to early stage and expanding business throughout Ireland.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series B
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 51
- Round size: Seed $549k–$2.2M; Series B $2.6M–$7.5M
- Lead/follow: 10% lead, 90% follow
Portfolio highlights
- Phorest — Join 8000+ spas, barbers, hair, beauty and nail salon owners using the #1 management, scheduling, POS and appointment booking system. Try Phorest now!
- SurgaColl — SurgaColl Technologies is a medical device company developing novel tissue regeneration products for the surgical treatment of diseases of the bone, cartilage and other human tissue. Based on technology developed at the Tissue Engineering Research Group (TERG) of the Royal College of Surgeons in Ireland (RCSI), headed by Professor Fergal O’Brien,the company aims to become a leader in the field of regenerative medical devices.
- Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Grant, Pre-Seed, Seed
- Geography: United Kingdom, Spain, Ireland
Investor stats
- Total investments: 95
- Round size: Seed $220k–$1.4M; Grant $22k–$1.6M; Pre-Seed $44k–$1.4M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- IDOVEN — IDoven develops products to detect heart problems at an early stage to prevent heart diseases.
- eBreathie — eBreathie is a pioneering digital health startup offering an integrated asthma management solution. Our system comprises a smart inhaler (a medical device) that not only tracks WHEN patients take their medication but also HOW they do it, creating a detailed inhalation profile for each use. Paired with a user-friendly mobile app for patients and acomprehensive patient management platform for doctors, we provide real-time feedback on inhalation efficacy, ensuring patients and healthcare professionals have the insights needed for optimal asthma management. Leveraging IoT and AI, our goal is to reduce emergency visits, asthma attacks, and hospitalizations while ensuring effective inhalation techniques and optimal patient care.
- Trak — Trak is a software tool for healthcare professional to provide AI-based tele-rehabilitation services like physiotherapy and others.
Fountain Healthcare Partners is an Irish based life science venture capital fund. Fountain is exclusively focused on the life science sector. Specific areas of interest to them are: specialty pharma, medical devices, biotechnology and diagnostics. They will deploy the majority of their capital in Europe with a strong focus on Ireland.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B, Series C
- Geography: Ireland, United States, France
Investor stats
- Total investments: 49
- Round size: Series A $6.6M–$44M; Series B $5.5M–$68M; Series C $3.3M–$110M
- Lead/follow: 43% lead, 57% follow
- Last fund: May invest from a new fund soon — raised $128M in 2019
Portfolio highlights
- Mainstay Medical — Mainstay Medical is improving quality of life for patients with chronic low back pain through innovative restorative treatment medical device solutions.
- Neuromod Devices — Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation.We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control oftheir own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle.Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
- XyloCor Therapeutics — XyloCor Therapeutics is a bio-pharmaceutical company intended to develop gene therapy for people with advanced coronary artery disease. The company's service focuses on developing gene therapy to stimulate the formation of new coronary blood vessels and serve areas of the heart that are not receiving adequate blood supply, enabling patientswith refractory angina who exhausted pharmacologic options to cure their cardiovascular diseases painlessly and cost effectively.
Technology-focused, investing capital and expertise to fuel growth in the most promising ideas and companies. Raised c.€600m across multiple funds and invest from seed to growth.We look for companies with potentially cutting-edge, category-defining businesses in markets including application software, IT infrastructure, communications, Internetand mobile. We help founders create and scale businesses globally. We work as a small team with diverse strengths accessing a community of over 200 founders. The teams and companies we back scale their investor base as they scale their business execution and ambition. We work closely with them in this process. Over the past 25 years have built a broad network of US and European investors and founders that share our vision and approach.Act is based in Dublin, Ireland.Our most recent funds are supported by the European Investment Fund.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 152
- Round size: Seed $823k–$5M; Series A $2.3M–$13M
- Lead/follow: 45% lead, 55% follow
- Last fund: Likely still investing — raised $164M in 2022
Portfolio highlights
- Deciphex — Deciphex - Transforming Digital Pathology - we are focussed on the development of applications for clinical and veterinary pathology that improve productivity
- SiriusXT — SiriusXT is transforming cell and tissue imaging with the SXT-100, the first commercial, laboratory scale soft x-ray microscope.
- Bounce Insights — Bounce Insights is a digital consumer research platform. It provides a direct link between brands and any consumer they needed to speak to by maintaining a community of active, engaged respondents on their mobile app.
Providing capital plus strategic, clinical, operational, financial, and commercial support to deliver the added value inventors seek.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Series C
- Geography: United States, The Netherlands, Switzerland
Investor stats
- Total investments: 168
- Round size: Series A $6.9M–$77M; Series B $8.6M–$103M; Series C $12M–$140M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $266M in 2023
Portfolio highlights
- Neuravi — Neuravi is an early stage company in the large emerging neurointerventional device market. Led by a team experienced in endovascular device development and global commercialization, the company's initial technology platform addresses acute ischemic stroke. In collaboration with international researchers and clinicians, the company seeks todevelop new understanding that will drive innovative solutions to treat this challenging and devastating disease. Neuravi was founded in 2009 and is headquartered in Galway, Ireland, home to many of the world’s leading medical device companies.
- Asceneuron — Asceneuron develops effective therapeutics for orphan tauopathies and Alzheimer’s disease. By focusing on areas of high unmet medical need, Asceneuron aspires to become a leading biotech company specialized in small molecule drug discovery for neurodegenerative diseases.Tauopathies are currently untreatable neurodegenerative diseases thatrapidly progress towards debilitating conditions. The appearance of deposits of the microtubule-associated tau protein as e.g. neurofibrillary tangles in neurons of the brain is a common feature of tauopathies that is shared with Alzheimer’s disease. Neuronal tau deposits are known to be a major contributor to neurodegeneration and mutations in the tau gene are causative of the tauopathy fronto-temporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).Due to increasing life expectancy, Alzheimer’s disease is viewed as one of the largest healthcare problems of this century, imposing a major economic burden on societies in the Western and developing world. Current treatment options provide limited benefits supporting the urgent need for more efficacious and better tolerated medicines that address symptomatic relief as well as disease progression.
- Mosanna Therapeutics — Mosanna is a Biotech company based in Basel with a commitment to improving patient outcomes and quality of life in high unmet need diseases, applying a precision medicine approach.
Discover start-up investing made simple. Access VC-led rounds, build your portfolio, and unlock growth at Ascentifi
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed, Series A
- Geography: Ireland
Investor stats
- Total investments: 8
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- CroíValve — CroíValve is a developed a safe, effective, easy to use, percutaneous solution for treating all patients with severe Tricuspid Regurgitation
- Vertigenius — Enhance patient care and treatment options for vertigo and dizziness with Vertigenius, enabling effective management and improved outcomes for your patients.
- X-BOLT Orthapaedics — X-Bolt Trauma Solutions for osteoporotic bone fixation. FDA 510(k) approved. Clinical studies include the WHITE One (n=100) and WHITE Four (n=1,140) randomized control trials.
Xenium Capital
Show more...Investment focus
- Industry: Medical Device, Health Care, Biotechnology
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 4
- Round size: Seed $2.5M–$3.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Atrian Medical — AtriAN is commercializing technology created at Mayo Clinic in the US. AtriAN is an Irish Medical Device company based in Galway--A powerful and prolific hub for medical devices.AtriAN uses a gentle energy, micro Pulsed Electric Fields (mPEF) to only ablate hyperactivity. The other tissues such as the myocardium are spared.
- ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
- Tympany Medical — Tympany Medical is a Needs-driven, Innovative MedTech StartUp based in the West of Ireland
Boole
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 4
- Round size: Seed $3.8M–$3.8M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Incereb — Incereb is an Irish medical device early stage company in the emerging neonatal intensive care unit (NICU) market. Founded in May 2011, Incereb is headquartered in Dublin, Ireland. The company designs and develops disposable Electroencephalography (EEG) and Cerebral Function Monitoring (CFM) products for term and preterm infants (neonates).These intuitive products are designed to be used with minimal training and will significantly reduce the time taken to set up the neonate for EEG and CFM monitoring. Their products are designed to interface with all brands of EEG and CFM recording equipment.Incereb is an award winning early stage company that plans to invest heavily in R&D, product design and development to evolve and extend its product range. Strategic alliances with leading Irish universities and hospitals enable Incereb to leverage home-grown scientific excellence to facilitate fast commercialisation of novel devices leading to rapid growth.
- ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
Early stage VC investments and funding for start-ups / founders in Ireland.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 109
- Round size: Seed $795k–$2.7M; Series A $1.6M–$6.6M
- Lead/follow: 32% lead, 68% follow
- Last fund: Likely still investing — raised $82M in 2022
Portfolio highlights
- Kayna — Enhance your SaaS platform's value by integrating Kayna's insurance solutions. Drive additional revenue and offer more to your users with every policy sold.
- CleverCards — The Platform for Contactless Cards. The CleverGift real-time payment platform offers gift cards, expenses, employee incentives, and travel foreign exchange.
- Digit Game Studios — Founded in 2012, DIGIT is a cross-platform game developer based in Dublin, Ireland. We are the largest game developer in the country with an international team of experienced, passionate game-makers. Our first game, Kings of the Realm, was launched in September 2014 and is available on browser, iOS, Android and Windows.
The AIB Seed Capital Fund was established in 2007 to provide venture capital for companies at the seed and early stages of development across a range of sectors throughout the Republic of Ireland. The Fund was established under the Enterprise Ireland Seed and Venture Capital Programme 2007-2012.The Fund has a total of €30m under managementwith AIB and Enterprise Ireland both committing €15m. It is managed by experienced managers with extensive expertise in making seed and early stage investments, adding value and facilitating business success.The Fund managers are empowered to make seed investments of up to approximately €500,000. Furthermore, the Fund has the capacity to make investments in later rounds to support the continued growth of investee companies.The Fund will be managed by Enterprise Equity Venture Capital and the Dublin Business Innovation Centre. This unique partnership brings together extensive regional and investment expertise.Enterprise Equity will evaluate and manage all investments outside the city and county of Dublin, as well as investments that require in excess of €250,000 from the fund within the city and county of Dublin.Dublin Business Innovation Centre (DBIC) will evaluate and manage all investments within the city and county of Dublin when the initial investment amount required from the Fund does not exceed €250,000.
Show more...Investment focus
- Industry: Software, Health Care, Medical
- Stage:Seed, Series A
- Geography: Ireland, United States, Jersey
Investor stats
- Total investments: 49
- Round size: Seed $549k–$3.3M; Series A $1.1M–$8.1M
- Lead/follow: 18% lead, 82% follow
Portfolio highlights
- NewsWhip — NewsWhip is the world's most comprehensive content discovery and analytics database. Their suite of products give customers the ability to predict which stories will be important today, and understand how to create successful content over the long term.NewsWhip serves over 500 of the world's leading publishers, brands and agencies,including: Reebok, the Washington Post, Conde Nast, Google, MasterCard, BuzzFeed, Time Inc., and more. NewsWhip Spike is their real-time, predictive content discovery dashboard — offering a one-stop view of what's important across both the web and 5 social networks. Spike is the only tool that discovers stories within 2 minutes of publishing, and predicts their spread across social.NewsWhip Analytics is a database of how audiences have engaged with stories across every social network over the long term. NewsWhip customers use Analytics to benchmark how they stack up against competitors and track engagement trends around events and seasons.
- Offr — Offr is the new way to buy and sell property, quickly and transparently.
- Metabolomic Diagnostics — Metabolomic Diagnostics is a deep-tech company specialized in the development of novel biomarker based diagnostic solutions for complex diseases. The company has developed an effective pipeline to firstly identify diagnostic biomarker panels and then translate these panels into clinical assays ready for application in the clinical laboratory.Thispipeline combines the biomarker multiplexing capabilities of Mass Spectrometry, a powerful analytical technology, with the company’s own informatics and statistics solutions to deliver diagnostic innovation. This is reflected in Metabolomic Diagnostics’ strong and versatile IP portfolio of technical innovations and biomarkers.Our VisionMetabolomic Diagnostics’ primary vision is to develop a portfolio of diagnostic solutions which can determine, early in a woman’s pregnancy,her risk of developing major complications much later in her pregnancy and thus enabling personalized care, adapted to each woman’s individual needs. Pregnancy complications like preeclampsia, gestational diabetes, preterm birth, and in-uterine growth restriction, all have the potential to severely impact on the well-being of mother and child.The company’s innovative diagnostic solutions will assist clinicians in re-imagining how these conditions are managed: our novel risk assessment tools are specifically developed in conjunction with prenatal care providers to ensure they make a difference that really matters. This in turn will enable clinicians to improve pregnancy outcomes globally.Our solutions will empower pregnant women: accurate pregnancy risk information will allow a pregnant woman, in partnership with her care provider, to determine what prenatal care is best for her pregnancy.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Seroba is a leading European life sciences venture capital firm focused on value creation through backing winning innovations in biotech and medtech.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Series A, Series B
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 48
- Round size: Series A $5.4M–$33M; Series B $4.6M–$105M
- Lead/follow: 35% lead, 65% follow
- Last fund: May invest from a new fund soon — raised $111M in 2017
Portfolio highlights
- Perfuze — Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. Perfuze is located within Galway City in the West of Ireland. The founders have over 30 years combined medtech experience within start-up and large corporations.Perfuze is developing innovative medical technology to treat acute ischemic stroke.Perfuze is developing innovative cathetertechnology to treat acute ischemic stroke. Their technology is intended to provide superior clinical outcomes in shorter procedural times; resulting in safe, cost-effective therapy. Perfuze was founded in 2018 by Wayne Allen and Liam Mullins. The founders have over 30 years combined medtech experience within start-up and large corporations. Perfuze is currently located in the Business Innovation Centre on the campus of the National University of Ireland, Galway, and is in the process of relocating to the IDA Business Park in Dangan, Galway.
- Novate Medical — NOvate Medical Technologies is a New Orleans-based medical device development company, focused on commercializing high-quality, low-cost, and sustainable medical products while addressing critical global health needs. NOvate’s first product offering, InfaClip, previously known as SafeSnip, is a patented disposable plastic obstetric device thatsimultaneously cuts, clamps, and shields the infant, mother, and birthing attendant from infection, aimed at reducing maternal and neonatal mortality in developing countries.
- INNOVO by Atlantic Therapeutics — INNOVO is a completely non-invasive, clinically proven and long-lasting solution to urinary incontinence and bladder weakness. See results in 4 weeks!
NDRC builds high-impact new ventures. By providing the people, time, space and investment needed at the earliest stages of dedicated commercialisation work, NDRC is creating companies worthy of commercial investment and with the ability to scale. The NDRC team has the breadth of knowledge and expertise in technology and markets. NDRC worksside-by-side with researchers, entrepreneurs and venture teams to turn great ideas into successful new ventures.By the end of 2014, NDRC’s portfolio of startup ventures had secured a cumulative €88m in follow-on investment from commercial investors, with a combined market capitalisation of approx. €220m.
Show more...Investment focus
- Industry: Software, Information Technology, E-Commerce
- Stage:Seed, Pre-Seed, Convertible Note
- Geography: Ireland, United States, United Kingdom
Investor stats
- Total investments: 110
- Lead/follow: no public data
Portfolio highlights
- Nory AI — Revolutionise your restaurant with Nory's restaurant management software. Streamline operations, boost profits, and enhance decision-making in one platform.
- Dataships — Dataships uses top level data privacy software to help your brand, no matter your location.
- Ceartas DMCA — Ceartas is the leader in piracy protection for creators, brands & enterprise. Powered by AI, we have the highest removal rate in the industry
Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical Device
- Stage:Series A, Seed, Series B
- Geography: United States, Canada, Israel
Investor stats
- Total investments: 76
- Round size: Seed $1M–$9.8M; Series A $1M–$20M; Series B $7M–$45M
- Lead/follow: 29% lead, 71% follow
Portfolio highlights
- FineHeart — Our mission is to address the unmet need of patients with sever heart failure
- 480 Biomedical — 480 Biomedical focuses on the development of a bioresorbable scaffold for treating occlusive disease in the superficial femoral artery (SFA). Its lead product, SFA scaffold, is a proprietary scaffold and delivery system for use in treating peripheral arterial disease in the SFA. The company was founded in 2011 and is based in Watertown,Massachusetts.
- HAYA Therapeutics — Pioneering next-generation therapies for fibrotic diseases. Learn more about our approach here.
Faber is a Lisbon-based venture capital firm investing in outstanding entrepreneurs who innovate at the intersection of science and technology to drive digital transformation and climate action. The firm combines a specialist focus on deep tech early-stage startups with dedicated funds, investment teams and expert advisors to actively helpfounders build global companies powered by AI/Data, Web3 or Ocean/Climate technologies.Faber’s unique approach in Southern Europe is led by an entrepreneurial management partnership and backed by notable thesis-driven institutions and private investors. Investing since 2013, the firm has been an early investor in hard tech companies such as Unbabel, SWORD Health, Codacy, iLoF or YData.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, SaaS
- Stage:Seed, Pre-Seed, Series A
- Geography: Portugal, United States, United Kingdom
Investor stats
- Total investments: 82
- Round size: Seed $549k–$5.5M; Pre-Seed $34k–$3.8M; Series A $5M–$25M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- Vyoma GmbH — Vyoma ensures satellite safety and real-time mapping of space objects with cameras on satellites paired with automation services.
- Apres — Apres is a distributed learning engine built to enable high-performance, user-friendly AI for the world.
- RESONIKS — It's data that drives resilient and sustainable supply chains. Implement SUPPLYZ solutions to gather real-time inventory data for your products and materials and use this data to automate your processes, offer new services and prevent supply chain disruptions. SUPPLYZ can be implemented for both industrial and consumer applications
Boole Investment Syndicate invests in new technology start-up's with scalability.
Show more...Investment focus
- Industry: Medical Device, SaaS, EdTech
- Stage:Seed
- Geography: Ireland, United States
Investor stats
- Total investments: 8
- Round size: Seed $642k–$1.6M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
- FeelTect — FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous.
- SymPhysis Medical — SymPhysis Medical's goal is to develop innovative technologies that treat a range of chronic diseases, putting the patient experience at the forefront of our design solutions to improve quality of life.About SymPhysis MedicalSymPhysis Medical's emergent technology, releaze, is a drainage technology to treat a common complication oflate-stage cancers, malignant pleural effusion (MPE). MPE causes significant shortness of breath and chest pain in up to 15% of patients with cancer.
Medtech Syndicate Nominee
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Seed, Series A
- Geography: Ireland
Investor stats
- Total investments: 3
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Kite Medical — Kite medical has developed a novel device for detecting Kidney Reflux in children with Urinary Tract Infections. The non-invasive diagnostic solution for kidney reflux removes the need for complicated procedures and a hospital visit. Kidney reflux is the most common urological disorder in childhood, affecting up to three per cent of young children.It is most prevalent from six months to five years of age. The condition may resolve as the child gets older, but left undiagnosed and untreated it can lead to permanent kidney damage and ultimately to kidney failure.
- Signum Surgical — A minimally invasive approach to primary Fistula healing through tissue apposition, without compromising the anal sphincter.
Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing inbreakthrough life science companies during a time of unique opportunity in space.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, Ireland, Singapore
Investor stats
- Total investments: 81
- Round size: Series A $7M–$95M; Series B $18M–$100M; Series C $20M–$105M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — raised $375M in 2021
Portfolio highlights
- Earlens — Earlens is the world's first and only hearing aid solution to directly vibrate the eardrum, delivering a more complete sound than any other hearing aid.
- Cerevance — Cerevance is a developer of novel therapeutics intended to advance new medicines for serious neurological diseases.The company's therapeutics applies it's technology called NETSseq to reveal transcriptional and epigenetic differences between specific cell types in mature human brains, enabling healthcare providers to detect and tackle theearly onset of various neurological diseases.
- Claret Medical — Claret Medical, Inc. develops a series of cerebral vascular protection systems for transcatheter aortic valve implantation, surgical, and other interventional procedures. The company’s products include Claret Medical Montage, a dual filter system and percutaneously delivered embolic protection device to capture and remove debris disloged duringvascular procedures; and small (6F) catheters that are inserted into the patient's right arm to protect the patient’s brain during interventional procedures where embolic debris might be released. It offers its products for use as an embolic protection system to capture and remove embolic material (thrombus/debris) that may enter the cerebral vascular system during endovascular procedures. The company was incorporated in 2009 and is based in Santa Rosa, California.
Business Venture Partners was founded in 2004 as a corporate finance adviser for SME/owner managed businesses. The investment team is comprised of Elliott Griffin, Ronan Smith, Edel Coen and Mark Ruane and the team skills combine deep industry knowledge with experience in venture investing, corporate finance and international expansion. Theteam works on behalf of its clients buying and selling companies, raising finances, working with start-ups and advising on strategic growth, business succession and owner exits.Since 2007, BVP has successfully raised and managed 10 Simple Green BES and EII Funds. They have invested, on behalf of their investors, in some of Ireland’s most innovative companies such as Celtic Bioenergy, EFT Controls, and UrbanVolt. Our investment strategy is to spread investments over project finance and a portfolio of high potential companies. Their philosophy is to work hard with each investment to deliver valuable support for the company promoters and build shareholder value for their investors.In 2016 BVP launched The 10th BVP Green EII Fund. The fund provides eligible investors with the opportunity to avail of up to 40% income tax relief and provides the investor access to a portfolio of cleantech companies and renewable energy projects. The 11th Green Fund will be launched in Q4 2017.
Show more...Investment focus
- Industry: Health Care, Information Technology, Medical
- Stage:Seed, Series A
- Geography: Ireland, Luxembourg, The Netherlands
Investor stats
- Total investments: 29
- Round size: Seed $658k–$4.7M; Series A $2.3M–$12M
- Lead/follow: 55% lead, 45% follow
Portfolio highlights
- FoodMarble — Your personal breath tester to identify food intolerances and reduce digestive symptoms. Ideal for managing IBS and SIBO, all from the comfort of home.
- HealthBeacon — Quality adherence support for your medication needs, contact our HealthBeacon team to discover what service we can provide you and your patients.
- P3 Hotel Software — P3 provides high-converting & custom booking solutions to help hotels maximise efficiency, conversion rate, and direct revenue. Integration with Oracle OPERA.
Expanding nanotechnology into business.
Show more...Investment focus
- Industry: Semiconductor, Manufacturing, Medical Device
- Stage:Seed, Series A, Series B
- Geography: Belgium, United States, Germany
Investor stats
- Total investments: 46
- Round size: Seed $3.3M–$21M; Series A $8.7M–$56M; Series B $12M–$100M
- Lead/follow: 54% lead, 46% follow
- Last fund: Likely still investing — raised $351M in 2024
Portfolio highlights
- Spectricity — Spectricity provides multispectral imaging solutions to enhance color accuracy and analysis capabilities in mobile and consumer electronics.
- Onera Health — Introduction to Onera sleep diagnostics and monitoring solutions
- Swave Photonics — Swave develops Spatial Computing, Holography, holographic chips, and holograms in the HXR chip to create 3D augmented and virtual reality and HUD Heads Up Displays
We invest in highly technical startups from idea-stage up to Series A.
Show more...Investment focus
- Industry: Health Care, Medical, Therapeutics
- Stage:Seed, Pre-Seed, Series A
- Geography: United States, Ireland, United Kingdom
Investor stats
- Total investments: 12
- Round size: Seed $3.2M–$5M
- Lead/follow: 25% lead, 75% follow
Portfolio highlights
- Olio Labs — Olio Labs utilizes AI for combo therapeutics, optimizing and minimizing side effects through automated discovery of protein interactions.
- Current Surgical — Surgery Reinvented - Current Surgical targets early-stage solid tumors in areas where traditional surgical techniques fail.
- Luminate Medical — Luminate Medical is developing LILY, the world's first pain-free and portable solution to prevent hair loss caused by chemotherapy.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Life Sciences Fund Amsterdam is an independent venture capital fund aiming to capitalize on new technological developments in the life sciences sector. It provides investment capital to fund high tech entrepreneurial activity in the Amsterdam Metropolitan Area in general and at the academic medical centres in particular. The fund is a specialistt fund, targeting companies that are developing commercially promising products and technologies in life sciences, including: pharmaceuticals, biotechnology, medical devices and other high technology opportunities that offer venture capital returns. The Fund focuses on seed and early stage companies, but also on pre-seed commercially viable academic projects.The close collaboration between the fund, the technology transfer offices of the Life Sciences Centre Amsterdam and the Amsterdam Biomed Cluster, enables the fund to facilitate the transfer of technology to the private sector and to provide emerging technology companies and university researchers with vital seed funding and specialized financial and technical assistance. The fund started in 2007 and is now fully invested.
Show more...Investment focus
- Industry: Medical Device, Medical, Communities
- Stage:Series A, Private Equity
- Geography: Ireland, The Netherlands
Investor stats
- Total investments: 3
- Lead/follow: 67% lead, 33% follow
Portfolio highlights
- Sigmascreening — Pucuk138 merupakan situs andalan Slot88 official gampang gacor dengan bet 100,200 dan 500 perak Auto Maxwin dengan winrate tertinggi.
- Neurent Medical — Discover NEUROMARK, a minimally invasive solution for Chronic Rhinitis that targets the posterior nasal nerve to provide lasting symptom relief.
Mayo Clinic Ventures is dedicated to quickly bringing answers to the people who need them most: the patients living with diseases and conditions that threaten to limit or even end their lives. Our team works closely with Mayo physicians and scientists to mine inventions, ideas and discoveries that will truly transform health care. Their dedicatedefforts bring significant financial support to Mayo's patient care, education and research efforts.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Series A, Seed, Series B
- Geography: United States, Ireland, China
Investor stats
- Total investments: 39
- Round size: Seed $1.4M–$8.2M; Series A $5M–$33M; Series B $6.5M–$69M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $2M in 2010
Portfolio highlights
- Anumana — Anumana is a new AI-driven health technology company from nference, developing and delivering ECG algorithms enabling early diagnosis and intervention
- JOGO Health — Wearbles and VR gaming to treat stroke, chronic pain and incontinence.
- Myosin Therapeutics — Advancing first-in-class therapies by targeting molecular motors (NMII) in oncology and neuroscience. Learn about our clinical trials for GBM, PDAC, and SUD.
Caju Venture Partners invests in MedTech in the European Union. Caju Venture Partners invests in entrepreneurs with high integrity who can establish great businesses and impact healthcare in the future.
Show more...Investment focus
- Industry: Health Care, Medical Device
- Geography: Ireland
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- FeelTect — FeelTect’s technology, Tight Alright, is a pressure sensing, connected-health device for measuring and monitoring sub-bandage pressure during compression therapy, primarily for the millions of people worldwide with venous leg ulcers (VLUs). Compression is a proven therapy for VLUs, however if it’s applied too loose, it’s ineffective, and if it’stoo tight, it’s dangerous.
The European Investment Bank (EIB) offers lending, borrowing, and treasury services primarily within the European Union. It provides project loans for public and private sectors, loans to banks and intermediaries, structured finance products, guarantees, and securitization instruments for debts. Additionally, EIB offers equity and fund investmentproducts, including infrastructure and environmental funds, as well as venture capital funds. EIB also supports microfinance and risk-sharing finance for research and innovation, and provides technical expertise for sustainable energy projects. Its services include infrastructure advisory, urban development support, guarantees for transport infrastructure, and funding for public-private partnerships and small- to medium-sized enterprises. The bank serves various sectors, including transportation, energy, health, education, and agriculture.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Energy
- Stage:Debt Financing, Post-IPO Debt
- Geography: France, Germany, The Netherlands
Investor stats
- Total investments: 294
- Round size: Post-IPO Debt $7.7M–$658M; Debt Financing $13M–$400M
- Lead/follow: 78% lead, 22% follow
Portfolio highlights
- IPT PowerTech — IPT PowerTech coverage, coupled with our extensive expertise in supply chain management, field implementation, and power systems, has made us one of the most capable companies in handling the most complicated and versatile projects in the MEA region and its neighboring countries.
- Interconnect Malta — Interconnect Malta is a government organization that develops and implements energy infrastructure projects.
- NVision Imaging Technologies — NVision Imaging Technologies is leveraging advances in quantum physics to enable the first routine, convenient and affordable use of Magnetic Resonance Imaging (MRI) for assessing early patient response to cancer treatment at the metabolic level.
Glanzmann Enterprises
Show more...Investment focus
- Industry: Medical, Health Care, Medical Device
- Stage:Series A
- Geography: Ireland
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Signum Surgical — A minimally invasive approach to primary Fistula healing through tissue apposition, without compromising the anal sphincter.
Artis Ventures has spent over a decade backing bold teams who take the hard path, building market-defining companies to re-shape, re-invent, and re-make industries.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Series A, Series B, Seed
- Geography: United States, India, Germany
Investor stats
- Total investments: 139
- Round size: Seed $2M–$40M; Series A $4M–$55M; Series B $20M–$127M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- ChefsFeed — Elevate your taste with mouth-watering recipes and award-winning lifestyle shows. Stream for free or join Tastemade+ for unlimited, ad-free access.
- Practice Fusion — 'Deliver better care more efficiently with the #1 electronic health record. Our industry-leading EHR was developed with feedback from over 150,000 professionals.'
- Second Front Systems — The continuous accreditation and deployment of commercial software is crucial for U.S. national security missions. With Second Front Systems' Game Warden platform, you'll be achieving exactly that.
Kernel Capital is the independent manager of The Bank of Ireland Kernel Capital Venture Funds, one of the largest and most active sources of equity finance on the island of Ireland. Kernel leverage their extensive network to enable their portfolio companies recruit the highest caliber people, to break into new international markets and to generaterevenues of scale. It is the only investment firm with venture capital Funds dedicated to both jurisdictions on the Island. Kernel have raised over €210M from investors which including their strategic partner Bank of Ireland, Invest NI, Enterprise Ireland, Galway University Foundation, The University of Limerick Foundation, The New York State Common Retirement Fund and undisclosed Family Offices. Consistently delivering strong financial returns for their investors Kernel have led more than 20 substantial trade sales to NASDAQ, NYSE, and LSE listed corporations.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Series A
- Geography: Ireland, United Kingdom, France
Investor stats
- Total investments: 91
- Round size: Seed $531k–$4.4M; Series A $1.4M–$9M
- Lead/follow: 51% lead, 49% follow
- Last fund: May invest from a new fund soon — raised $34M in 2013
Portfolio highlights
- Cirdan — Cirdan provides highly reliable, innovative LIS & imaging solutions for the acceleration & enhancement of diagnosis, optimized for pathology & clinical lab.
- Pretto — Pretto is the only truly transparent online real estate price comparator.Pretto accompanies you until the signing of your loan, free of charge and without commitment.
- Pilot Photonics — Welcome to Pilot Photonics, a laser product development company in Dublin, Ireland. We provide optical frequency combs and tunable lasers.
Transformeer merkbetrokkenheid met ons Pulse-Echo protocol voor realtime doelgroepkalibratie en narratieve balancering via autonome perceptie-arrays.
Show more...Investment focus
- Industry: Medical, Health Care, Biotechnology
- Stage:Series A, Series B
- Geography: United States, Ireland
Investor stats
- Total investments: 25
- Round size: Series A $6.1M–$30M; Series B $16M–$50M
- Lead/follow: 12% lead, 88% follow
Portfolio highlights
- TriSalus Life Sciences — Surefire Medical, based in Westminster, Colorado, was founded in 2009 to develop a novel infusion system for the interventional radiology market. The Surefire's Infusion System is designed to precisely deliver embolic agents through the sophisticated expandable tip portion of its catheter. Because of this differentiated expandable tip, whichcollapses in forwarding flow to maintain blood flow and dynamically expands to the vessel wall in reverse flow to minimize reflux, Surefire's Infusion System is designed to substantially reduce damage to healthy tissue.
- Enable Injections — Enable Injections designs, manufactures, and sells wearable delivery devices for injectable drugs. The Enable Injections products can deliver drugs directly from standard vials supplied by all pharmaceutical companies, can reconstitute powdered drugs into liquids as a part of the injection procedure, can inject very viscous drugs, and can inject upto 20 ml. Such products are called bolus injection systems. No other existing drug delivery device can accomplish all of these tasks. Approximately 900 new drugs are being developed that may require bolus injection technology like that being developed by Enable Injections. The total market is expected to reach $8 billion within ten years. Partisan principals have supplied 10% of the seed capital to Enable Injections. It also delivers a controlled flow of up to 50 ml of a biologic through an automatically inserted needle. Enable Injections also offers a version of the drug delivery platform that may connect to smartphones via Bluetooth. It also utilizes any standard container closure system, including syringes or vials; automatically warms and can automatically mix lyophilized solutions.Enable Injections was founded in 2010 and is headquartered in Cincinnati, Ohio, USA.
- Ponce De Leon Pharmaceuticals — Ponce De Leon Pharmaceuticals is a privately financed development stage company, committed to the extension of human health span, endeavoring to offer more healthy years of living. In conjunction with the Buck Institute for Research on Aging, the Company has developed a formulation comprised of GRAS (Generally Regarded As Safe) components. Thisformulation has been shown to radically increase mean lifespan in the invertebrate model (C. Elegan), well beyond any previously published data on drugs or compounds. Testing has now begun at the Buck Institute in the mammalian model (mouse), and the Company hopes to have a patent pending product available to the public at the conclusion of those studies, or in about three years.
Gilde Healthcare is a specialized European healthcare investor managing two business lines: a lower mid-market buy-out fund and a venture & growth capital fund. It has over €800 million ($900 million) under management and is actively looking to lead new investments in digital health, diagnostics, medical devices, therapeutics and healthcareservices. Gilde successfully builds healthcare businesses across Europe and US, investing up to €35 million in a single portfolio company.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series B, Series C, Series A
- Geography: United States, The Netherlands, Germany
Investor stats
- Total investments: 124
- Round size: Series A $8.8M–$63M; Series B $15M–$120M; Series C $21M–$75M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely still investing — raised $786M in 2023
Portfolio highlights
- Splice Bio — Splice Bio is a gene therapy company based on technology developed in the Muir Lab at Princeton University. The company is developing novel gene therapies based on its proprietary intein platform technology to treat patients that suffer from incurable genetic diseases. The company’s platform has the potential to address two existing limitations ofadeno-associated viruses (AAVs), both by increasing the size of the cargo gene that can be delivered and by expanding the range of tissues that can be targeted.
- ProVerum Medical — The ProVee stent from Proverum Medical uses 3-D geometry which mirrors and engages with the anatomy of the prostate. The system alleviates Lower Urinary Tract Symptoms (LUTS) by opening the prostatic urethra, applying radial force to the prostatic lobes.
- Endovascular Engineering — Endovascular Engineering is a preclinical stage company developing novel mechanical thrombectomy solutions to address peripheral indications.
COSIMO digital, previously COSIMO Ventures, is a pioneering digital asset management firm offering asset management, advisory, custody, broker-dealer, and blockchain and Web3 development services.
Show more...Investment focus
- Industry: Enterprise Software, Blockchain, Sports
- Stage:Seed, Series A
- Geography: Japan, Ireland, United States
Investor stats
- Total investments: 4
- Lead/follow: no public data
Portfolio highlights
- Defactor — Globally empowering businesses to tokenise real-world assets by offering decentralised open-source financial technology. Unlock a new financial future.
- ICHI — Grow any token with low-slippage, on-chain liquidity
- BEASY — BEASY Wallet & Forge makes it easy for collectors and creators to mint, buy, sell, trade, and manage their own NFTs. No crypto knowledge required!
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!TMC Venture Fund invests in entrepreneurs who are shaping the future of health care.TMC Venture Fund's mission is to serve the world's health, education, and research needs.TMCVF is the venture capital arm of Texas Medical Center Corporation.
Show more...Investment focus
- Industry: Health Care, Life Science, Medical Device
- Stage:Series A
- Geography: United States
Investor stats
- Total investments: 6
- Lead/follow: no public data
Portfolio highlights
- NUA Surgical — NUA Surgical is an award-winning Irish MedTech company developing innovative solutions in obstetrics and gynaecology.
- CrossBridge Bio — CrossBridge Bio is a biotechnology company focused on innovating ADC Therapeutics through stable dual-linker payload technology.
- Alleviant Medical — Interventional therapy for congestive heart failure
Sanara MedTech is in the business of improving patient outcomes through advanced healing solutions and biotechnology. Call us at 817-529-2300!
Show more...Investment focus
- Industry: Medical, Biotechnology, Medical Device
- Stage:Corporate Round
- Geography: Ireland
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Biomimetic Innovations — Biomimetic Innovations is a medical device company that specializes in the development and commercialisation of synthetic biomaterial technology for tissue repair.
Welcome to The University of Vermont Health Network, five partner hospitals serving the residents of Vermont and northern New York. With over 4,000 health care providers throughout our region, they work together to offer high-quality care more cost-efficiently and as close to home as possible. Strengthened by their connection, each of theirhospitals remains committed to its local community and to the heart and science of medicine: compassionate, personal care shaped by the latest medical advances and delivered by highly skilled experts.
Show more...Investment focus
- Industry: Medical, Biotechnology, Fashion
- Stage:Seed, Series B
- Geography: United States, Ireland
Investor stats
- Total investments: 3
- Lead/follow: no public data
Portfolio highlights
- BioFactura — BioFactura has developed the StableFast™ Biomanufacturing Platform, a novel system to rapidly generate stable NS0 cell lines for biopharmaceutical manufacturing. The elements of this system include a chemically-defined, serum- and cholesterol-free production medium and pre-adapted parental cells, modular expression vectors that utilize a patentedselection strategy, and a proprietary growth supplement that permits rapid generation and cloning of cell lines. This platform is simple to use, fast, and productive. A clonal production cell line can be developed and scaled up to yield over one gram of product in less than eight weeks.
- THEYA Healthcare — Creators of the Post Surgery Bra proven to heal. Hypoallergenic and Antibacterial Underwear for Sensitive Skin, Post Partum, and Menopause using soft, safe & sustainable bamboo. Post-Op wear from labiaplasty recovery to stoma briefs. Mastectomy and breast cancer care specialists. Sizes XS to 4XL & Worldwide Shipping!
- Veralox Therapeutics — Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes. Based on an understanding of the molecular mechanisms of these diseases, these efforts will lead to new treatment paradigms and better outcomes for patients.
Nipro Corporation is a Japanese medical equipment manufacturing company. Founded in 1954, the company is headquartered in Osaka and is listed on the Tokyo Stock Exchange and the Osaka Securities Exchange.
Show more...Investment focus
- Industry: Health Care, Medical Device
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 1
- Lead/follow: 100% lead, 0% follow
Portfolio highlights
- Venari Medical — Venari Medical’s mission focus is on the innovation of unparalleled safe, effective, patient-centered medical devices that improve quality of life for those with debilitating vascular disease.Venari Medical are developing BioVena™ - a more effective, less invasive, and faster treatment for all venous disease patients. It is uniquely positioned todisrupt current treatment practices which have seen only medium level innovation in the past decade. The team is based at Ireland's medtech cluster in Galway.Only 1.3 million of the 120 million people in the US & EU who suffer from venous disease currently receive endovenous treatment each year. 3 million venous ulcer patients are completely unserved, using ineffective compression bandaging. Venari Medical offers an unrivaled lower risk and unparalleled effective non-thermal treatment which will allow more patients who suffer from Venous Disease to access effective treatment.The indication for the use of superficial venous ablation is also set to widen to treat venous ulcers that currently incur annual costs of $33Bn to insurers in the US & EU. The Venari Medical technology can be used as a safe and effective treatment for the whole spectrum of Venous Disease from varicose veins to active venous ulcers.
A design-led software company, a specialist in designing, building and operating scalable, secure cloud-native applications, with a venture capitalist twist.
Show more...Investment focus
- Industry: Software, SaaS, Information Technology
- Stage:Pre-Seed, Seed
- Geography: Ireland, United Kingdom
Investor stats
- Total investments: 13
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Meeow — Meeow is an AI-powered video networking platform.
- Rove — Rove has developed a cloud-based software platform that allows consumers to book adventure travel experiences and facilitates industry partners in growing ancillary revenues from tourism activities.
- Simply Get Results — Simply gives you user-friendly tools to identify the skills you need, the skills you have, close skill gaps and future-proof your workforce.
Grimpeur Holdings is a venture capital investment firm.
Show more...Investment focus
- Industry: Health Care, Medical Device, Health Diagnostics
- Stage:Seed
- Geography: Ireland
Investor stats
- Total investments: 1
- Lead/follow: no public data
Portfolio highlights
- Novus Diagnostics — Sepsis causing pathogen diagnostics under 15 minutes
Kidron Capital Assets LP is the Women's Health Venture Capital Fund. Kidron’s investments will include a mix of medical devices, diagnostics, services, therapeutics, and digital health.
Show more...Investment focus
- Industry: Health Care, Medical Device
- Stage:Series B
- Geography: France
Investor stats
- Total investments: 2
- Lead/follow: no public data
Portfolio highlights
- May Health — May Health is developing a modern treatment - Ovarian Rebalancing - designed to restore ovulation for people with polycystic ovary syndrome.
- NUA Surgical — NUA Surgical is an award-winning Irish MedTech company developing innovative solutions in obstetrics and gynaecology.
Bayern Kapital (founded at the end of 1995) is a wholly owned subsidiary of the LfA Foerderbank Bayern (Bavaria‘s development bank). Bayern Kapital’s objective is to finance research and development as well as the market launch of new products, product diversifications, and expansion of the market share.The requesting company has to be located inBavaria. Industries are e. g. IT/software, life sciences, new materials, micro-systems and environmental technologies.Bayern Kapital and its funds have invested in more than 250 companies and currently manages funds to the value of EUR 340 m. The five investing funds currently managed by Bayern Kapital are Seedfonds Bayern, Clusterfonds Start-Up!, Innovationsfonds, Innovationsfonds EFRE and Wachstumsfonds Bayern.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Series A
- Geography: Germany, United States, Finland
Investor stats
- Total investments: 209
- Lead/follow: no public data
Portfolio highlights
- abaut — Abaut GmbH delivers AI-powered process intelligence for quarries, mining sites, and construction operations. SiteView OS gives real-time visibility into quarry process monitoring, mass flow, mixed fleets, and Load-Haul-Dump cycles. With smart analytics, teams work faster, reduce delays, and replace manual analysis with clear, data-driven decisions.
- Filics — A scalable transport solution for standardized load carriers with a minimum energy footprint
- Nuclidium — NUCLIDIUM is a clinical-stage radiopharmaceutical company that develops novel radionuclide PET tracers for precision diagnostics. Using copper isotopes, Copper-61 for diagnostics and Copper-67 for therapeutics, the company is creating a differentiated platform with the potential to overcome existing limitations in radiotheranostics.
Silicon Valley Bank is the financial partner of the innovation economy; helping individuals and investors in the innovation ecosystem achieve extraordinary outcomes.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Debt Financing, Series B, Series A
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 401
- Lead/follow: no public data
Portfolio highlights
- Thumbtack — Thumbtack is a technology leader building the modern home management platform. Through the Thumbtack app, homeowners can effortlessly manage their homes — confidently knowing what to do, when to do it, and who to hire. Bringing the $500 billion home services industry online, Thumbtack empowers millions of homeowners to fix, maintain, and improvetheir most valuable asset. The company is backed by Sequoia Capital, Tiger Global Management, Javelin Venture Partners, Baillie Gifford, and Capital G, among others.
- DataPelago — DataPelago provides big data analytics solutions. They also provide a data analytics platform that offers hardware and software based products. The platform also provides solutions for extracting insights from data of, speed, or structure at performance and cost levels unsurpassed in the industry.
- Mesa — Earn points on your mortgage. With the first ever Homeowner Membership Platform, Mesa makes homeownership more affordable and rewarding. Join Mesa and get rewarded for your home.
Triventures is a global, early stage fund that invests in exceptional entrepreneurs. We partner with disruptive ventures with innovative breakthroughs in healthcare and beyond. Our vision is to create a better, healthier future through data driven solutions and cross industry convergence.
Show more...Investment focus
- Industry: Health Care, Medical Device, Medical
- Stage:Series B, Seed
- Geography: United States, Israel, Ireland
Investor stats
- Total investments: 42
- Lead/follow: no public data
Portfolio highlights
- FEMSelect — More than half of women over 50 are living with Pelvic Organ Prolapse. Learn about EnPlace, the minimally invasive approach to Pelvic Organ Prolapse.
- Future Family — Our loans for IVF & egg freezing make it easy for you to get started quickly with fertility treatment. Learn more about our Fertility Financing & Loans today!
- Brightside Health — Get anxiety and depression treatment online from licensed psychiatric providers and therapists. No need to wait, start a free consultation online today.
Medical Device VC funding in Ireland at a glance
Stats across 179 deals from 142 investors.
Access all 142 VC funds in Ireland Medical Device startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical Device VC Funds in Ireland investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 142 VC funds investing in Ireland Medical Device startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!